A study of the urinary porphyrins and porphyrin precursors in patients with malignant disease receiving diethylstilbestrol

A. Theologides, B. J. Kennedy, C. J. Watson

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Administration of diethylstilbestrol, diethylstilbestrol diphosphate, testosterone propionate and 17 alpha-hydroxyprogesterone-n-caproate did not alter the urinary excretion values for coproporphyrin, uroporphyrin, porphobilinogen and delta aminolevulinic acid in nonporphyric subjects. In 1 patient with latent porphyria a slight increase of δ-ALA was observed after diethylstilbestrol but PBG and porphyrin excretion were unaffected. This individual had received stilbestrol previously over a 2 year period.

Original languageEnglish (US)
Pages (from-to)391-395
Number of pages5
JournalMetabolism
Volume13
Issue number5
DOIs
StatePublished - May 1964

Bibliographical note

Funding Information:
From the Department of Medicine, University of Minnesota Hospital, Minneapolis, nesota . Aided in part bg a grant from the U.S.P.H.S. and by the John am! Mary Porphyria Research Fund of the Dept. of Medicine, Unimrsity 4 Minnesota. Received fot pub&cation Jan. 9, 1964.

Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.

Fingerprint Dive into the research topics of 'A study of the urinary porphyrins and porphyrin precursors in patients with malignant disease receiving diethylstilbestrol'. Together they form a unique fingerprint.

Cite this